We came across a bullish thesis on Harrow, Inc. on Penny Insight’s Substack. In this article, we will summarize the bulls’ thesis on HROW. Harrow, Inc.’s share was trading at $38.23 as of August 19th. HROW’s trailing and forward P/E were 9.64 and 3.33k respectively according to Yahoo Finance.
Photo by Michael Longmire on Unsplash
Harrow, Inc. is a U.S.-based ophthalmology pharmaceutical company rapidly expanding its branded portfolio with products such as VEVYE, IHEEZO, TRIESENCE,...
